These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4629309)

  • 1. A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.
    Freeman H; Mehta IS
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):470-7. PubMed ID: 4629309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
    Elie R; Morin L; Tétreault L
    Encephale; 1972; 61(1):32-52. PubMed ID: 4403697
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of indication for use of antiparkinson medication. A follow-up study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    Dis Nerv Syst; 1971 Aug; 32(8):538-41. PubMed ID: 5094160
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of methamidoline in the treatment of parkinson-like manifestations due to neuroleptics].
    Arnone A; Parodi A
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1126-42. PubMed ID: 5143724
    [No Abstract]   [Full Text] [Related]  

  • 5. Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    J Clin Pharmacol New Drugs; 1971; 11(5):367-70. PubMed ID: 4998432
    [No Abstract]   [Full Text] [Related]  

  • 6. Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism.
    Fann WE; Lake CR
    Am J Psychiatry; 1976 Aug; 133(8):940-3. PubMed ID: 782262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
    Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
    Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
    Ciuca I; Bulandra R; Serbanesco A; Ninosu N
    Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
    [No Abstract]   [Full Text] [Related]  

  • 9. The antiparkinson properties of amantadine in drug-induced parkinsonism.
    Kelly JT; Abuzzahab FS
    J Clin Pharmacol New Drugs; 1971; 11(3):211-4. PubMed ID: 5211353
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of the Soviet preparation midantan in the treatment of the Parkinsonian syndrome].
    Balunov OA; Bazhin EF; Morozova ES; Fedotenkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1178-81. PubMed ID: 4417237
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the need for prophylactic antiparkinsonian medication in psychotic patients treated with neuroleptics.
    Manos N; Lavrentiadis G; Gkiouzepas J
    J Clin Psychiatry; 1986 Mar; 47(3):114-6. PubMed ID: 2869027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of extrapyramidal manifestations induced by neuroleptics].
    Bordeleau JM; Tétreault L
    Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
    [No Abstract]   [Full Text] [Related]  

  • 15. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

  • 16. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A double-blind study on the effect of dexetimide in the control of neuroleptic-induced extrapyramidal side-effects].
    Chen Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):197-9, 251. PubMed ID: 1683277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF; Ni L
    Exp Neurol; 1998 Aug; 152(2):238-42. PubMed ID: 9710523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a new neuroleptic "thiothixene" (p-4657 b).
    Gómez-Martínez I
    Psychiatr Neurol (Basel); 1967; 153(4):219-25. PubMed ID: 5340209
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug-induced Parkinson's syndrome].
    Degkwitz R
    Dtsch Med Wochenschr; 1972 Jun; 97(22):882. PubMed ID: 5032182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.